FDA Inspection 1160701 — Reese Pharmaceutical Company
The FDA completed an inspection of Reese Pharmaceutical Company on Dec 8, 2021 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2021
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Cleveland, OH (United States)